Dehydrogenases/Reductases for the Synthesis of Chiral Pharmaceutical Intermediates

Author(s): Yan Huang, Nan Liu, Xuri Wu, Yijun Chen

Journal Name: Current Organic Chemistry

Volume 14 , Issue 14 , 2010

Become EABM
Become Reviewer


The increasing trend of chiral drugs in the pharmaceutical industry has promoted greatly on the development of numerous biocatalytic routes in combination with chemical methods. Because the resulting chiral alcohols are particularly valuable intermediates and precursors for the synthesis of chiral drugs, dehydrogenases and reductases have been extensively used in the synthesis of chiral compounds from ketone substrates with high regio- and stereo-selectivities. In this review, biocatalytic processes carried out by dehydrogenases and reductases are described for the synthesis of chiral intermediates for a wide variety of pharmaceuticals, including antidepressants, anti-anxieties, anti-asthmatics, anti-hypertensives, cholesterol-lowering agents, NK1 antagonists, ACE inhibitors and β- Lactamase inhibitors.

Keywords: Biocatalysis, Dehydrogenases, Reductases, Chiral intermediates, Stereoselectivity, Cofactor regeneration

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [1447 - 1460]
Pages: 14
DOI: 10.2174/138527210791616795
Price: $58

Article Metrics

PDF: 14